Apiject LogoFareva and ApiJect Systems today announced a licensing agreement to fill-finish more than 500 million injectable drug doses per year.

Under the agreement, Fareva intends to invest more than $56.5 million to install three blow-fill-seal production lines with support from the Government of France through the France Relance industry initiative, as well as the Investments for the Future Program (PIA).

Get the full story at our sister site, Drug Delivery Business News.